Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding CorMedix Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CRMD: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders10190−11
Shares18.7M17.3M−1.47M (−7.9%)
Value$70.5M$73.2M+$2.76M (+3.9%)

New holders (8)

Institutions that held CorMedix Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CRMD in Q1 2024
InstitutionSharesValue% of portfolio
Sigma Planning Corp31,324$132.8K0.00%
Toroso Investments, LLC14,105$59.8K0.00%
HRT Financial LP13,721$58.0K0.00%
Engineers Gate Manager LP12,723$53.9K0.00%
Cetera Investment Advisers12,152$51.5K0.00%
Northwestern Mutual Wealth Management Co283$1.20K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC11$460.00%
CWM, LLC5$00.00%

Sold out (19)

Institutions that held CorMedix Inc. at the end of Q4 2023 and filed for Q1 2024 without it.